DIABETES RESEARCH RIGHT NOW! #22: New Treatment Eliminates Insulin for Most Insulin-Dependent Patients!

From the first moment I discovered I had been diagnosed with DIABETES, I joined a HUGE “club” that has been rapidly expanding since it stopped being a death sentence in the early 20th Century. Currently, there are about HALF A BILLION PEOPLE who have Type 2 Diabetes. For the past 3500 years – dating back to Ancient Egypt – people have suffered from diabetes. Well, I’m one of them now… Not one to shut up for any known reason, I added a section to this blog…

Every month, I’ll be highlighting Diabetes research that is going on RIGHT NOW! Harvested from different websites, journals and podcasts, I’ll translate them into understandable English and share them with you. Today: “Diabetes Breakthrough: New Treatment Eliminates Insulin for 86% of Patients”

OK, I read the SECOND article at the link below after I ran into the last few sentences from the SciTechDaily website report by something calling itself “United European Gastroenterology.

“Looking ahead, the researchers plan to conduct larger randomized controlled trials to further validate these findings. Dr. Busch added, ‘We are currently conducting the EMINENT-2 trial with the same inclusion and exclusion criteria and administration of semaglutide, but with either a sham procedure or ReCET. This study will also include mechanistic assessments to evaluate the underlying mechanism of ReCET.’ Reference: ‘Durable effects of duodenal ablation using electroporation combined with semaglutide to eliminate insulin therapy in patients with type-2 diabetes; the 24-month results.’” C.B.E Busch et al., 14 October 2024, UEG Week 2024.”

Now, I don’t know about you, but when I see phrases like “the same inclusion and exclusion criteria” and “mechanistic assessments to evaluate the underlying mechanism”…I get suspicious that the gobbledygook is being written to cover up a dearth of facts with absurdly used terms substituted for straightforward language.

I could translate the above into something more understandable, but I needed to check this whole article out.

So, I went to my “go to” reliability monitor: the Mayo Clinic. I live in the birth state of the Mayo brothers and like most Minnesotans, know how the clinic came about – and because of its immense reach, also know someone who has either worked there or who has been treated for some mysterious ailment there. That’s their reputation: if it’s a challenge, let’s go to the Mayo.

It has worked with sports heroes, rulers of nations, religious leaders, and writers: Lou Gehrig, Muhammad Ali, Former King Hussein of Jordan, George HW Bush and his wife Barbara, Billy Graham, the Dalai Lama, and Helen Keller, and Ernest Hemingway.

The article from the Mayo Clinic reports in February of 2024 on the process. “This novel procedure could potentially transform the treatment landscape for type 2 diabetes, offering a more efficient and less burdensome alternative to current pharmacotherapies for some individuals. The procedure's potential to reduce the daily burden associated with diabetes management, coupled with the significant preliminary results of the REGENT-1-US trial, positions ReCET as a promising alternative in the diabetes care arsenal.”

I’ve run on long enough. Next time, I’ll come back to a far-more detailed description of what the two trials – one in the US (REGENT-1-US) and one in Europe (Re-Cellularization via Electroporation Therapy (ReCET) with semaglutide) – discovered.

Links: https://www.mayoclinic.org/medical-professionals/digestive-diseases/news/researchers-study-novel-endoscopic-therapy-for-type-2-diabetes/mqc-20563134#:~:text=ReCET%20is%20nonthermal%20procedure%20that,delivers%20PEF%20to%20the%20duodenum. https://scitechdaily.com/diabetes-breakthrough-new-treatment-eliminates-insulin-for-86-of-patients/
Image: https://asploro.com/wp-content/uploads/2019/12/Diabetes-Research_Open-Access.jpg